Collaborate Disseminate
Researchers have published the results of a clinical trial evaluating the efficacy of an immunotherapy drug in treating a particularly aggressive form of lung cancer. Tarlatamab produced promising results, demonstrating antitumor activity and improving… Continue reading Immunotherapy drug proves promising for deadly small cell lung cancer
Researchers have developed a liquid gel that solidifies when injected into a solid tumor, is visible on a CT scan, and can slow-release cancer-fighting treatments. Using the gel in combination with immunotherapy improved survival in mice and affected d… Continue reading Multifunctional gel developed to treat solid cancer tumors & metastases
Immunotherapy is a promising cancer treatment, but it can take too long to administer. In a new study, scientists at UCLA have taken steps towards an “off-the-shelf” therapy that could be mass produced and quickly rolled out to patients with a variety … Continue reading “Off-the-shelf” cancer immunotherapy inches closer with new mouse study
Vaccines against cancer are somewhat of a holy grail for medicine – but what if you could repurpose a vaccine you’ve already had? Scientists have demonstrated in mice a way to trick the immune system into attacking tumors by mistaking them for a pathog… Continue reading Bacteria-based cancer therapy reactivates vaccines you’ve already had
Researchers have developed an alternative way of desensitizing very young peanut-allergic children to the food. Under-the-tongue immunotherapy was found to be safer and easier to administer than the current treatment and may provide another method of c… Continue reading Under-the-tongue immunotherapy a treatment for childhood peanut allergy
According to the American Cancer Society, around 150,000 new cases of rectal and colon cancer are diagnosed each year. And while the number is slowly trending downward, thanks to an increase in pre-emptive age-related screening, it’s still the third bi… Continue reading In a world first, scientists discover ‘roadmap’ to beating bowel cancer
According to the Crohn’s & Colitis Foundation, 1.6 million Americans have irritable bowel disease (IBD), with the numbers increasing each year. Around 70,000 new cases are diagnosed annually.
Tags: King’s College London, irritable-bowel-disease, Chronic, Cells, The Immune System, Immunotherapy, Gut Bacteria, Inflammatory, Cancer
Continue reading Immune cell discovery offers hope for irritable bowel disease sufferers
Scientists have discovered a previously unknown type of immune cell that develops in people who successfully fight off cancer. Unlike other killer T cells, these home in on multiple cancer-associated targets at once, preventing new tumors forming for u… Continue reading Super killer T-cells discovered in patients who beat cancer
A phase 1 clinical trial exploring the use of fecal transplants to supplement immunotherapy treatment for melanoma has found it to be safe and has the potential to improve patients’ response to treatment.Continue ReadingCategory: Medical, ScienceTags: … Continue reading Fecal transplants may boost the success of melanoma treatment
New research has discovered that a fundamental nutrient found in cells is key to maintaining the body’s cancer-destroying immune response. The discovery may lead to more effective ways of treating the disease.Continue ReadingCategory: Medical, ScienceT… Continue reading Upping levels of key nutrient maintains immune cell response to cancer